ARCHIVES

Vasopermeation Technology Awarded Patent For CA Firm.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

General Says HHS Shift of Breast Cancer funds Could Leave Army in “Untenable Position”

March 12, 1993

Jury Awards $14 Million To Medenica Patient

February 24, 1995

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005

New Biologic Therapies Showing Promise In A Variety Of Advanced Solid Tumors

June 29, 2001

NCI subsidy of $2 million paid major expenses of rescheduled meeting.

April 15, 2005